Japan Cellulite Treatment Market currently holds 6.2% share in the global market

[272 Pages Report] Cellulite is a health condition which is more prevalent in women. With the growing health related complexities witnessed in women, there’s also a growth in rate of people suffering from cellulite. A new research report by Future Market Insights revolves around examining the current scenario of global cellulite treatment market as well as forecast …

France and U.K Veterinary Lasers Market expected to grow with a CAGR of 10.3 &10.0% from 2022 to 2028

[Report of 329 Pages] From 2022 to 2028, the market for veterinary laser products is expected to grow at a CAGR of 9.9%, with a projected market value of about US$ 336.5 Mn in 2028. As per Future Market Insights’ projections, the therapeutic lasers holds a substantial share of over 43.4% in 2021 in the overall Veterinary …

Western Europe and Eastern Europe market together are set to account for 30.6% of the global market share in 2022

[246 Pages Report] Revenue from the global Vulvodynia Treatment Market is currently valued at US$ 5.6 Bn, and is projected to top US$ 8 Bn by 2028, increasing at an impressive CAGR of 6.3% over the period of 2022 to 2028. Future Market Insights (FMI) has published a new research report on vulvodynia treatment market. The report has been titled, “Vulvodynia Treatment Market: Global …

Zika Virus Testing Market is likely to grow from US$ 4.9 Million in 2023 to US$ 6.8 Million by 2033

According to FMI, the market for testing for the Zika virus will likely increase from US$ 4.9 million in 2023 to US$ 6.8 million by 2033. The market is anticipated to experience a CAGR of 3.4% over the course of this forecast period. The rising incidence of Zika virus infection is a major factor driving …

Laboratory Supplies Sales to top US$ 81 Billion by 2032 | backed by Increased R&D Funding for Biotech and Pharma Research | FMI Report

The global demand for Laboratory Supplies is projected to increase at a CAGR of 8% during the forecast period between 2022 and 2032, reaching a total of US$ 81.61 Billion in 2032, according to a report from Future Market Insights (FMI). From 2017 to 2021, sales witnessed significant growth, registering a CAGR of 6%. Rise …

Rising Incidence of Cancer Cases to Propel the Growth in the Market for Intratumoral Cancer Therapies | FMI Study

A recently published study by FMI expects the global Intratumoral Cancer Therapies market to garner a market value of US$ 212.96 Billion in 2023 and is expected to accumulate a market value of US$ 552.36 Billion by registering a CAGR of10% in the forecast period 2023-2033. Growth of the Intratumoral Cancer Therapies market can be …

North America to Procure 40% Market Share for IgA Nephropathy Market in the Forecast Period 2023 to 3033 | FMI Study

During the forecast period 2023-2033, the IgA nephropathy market is expected to grow at a value of 7.5% CAGR, according to Future Market Insights. By the year 2033, the global market for IgA nephropathy is expected to rise up to a market valuation of US$ 85 Billion. Key factors such as high prevalence of kidney …

Combined Sales of Anti-biofilm Wound Dressing is expected to reach US$ 1939.45 million by 2033 | Development in Telehealth Platforms Surges the Sales of Anti-biofilm Wound Dressing.

The net worth of the market share of the anti-biofilm wound dressing is predicted to reach from US$ 782.60 million in 2023 to over US$ 1939.45 million by 2033, recording a CAGR of 9.5% between 2023 and 2033. Incidence rates for chronic and acute wounds are expected to increase which is, driving demand for anti-biofilm wound dressings. Besides antimicrobial …

Personalized Medicine Market through Personalized Nutrition & Wellness to Surge at over 6% CAGR from 2022 to 2033

The global Personalized Medicine Market is valued at US$ 315.7 Billion in 2022 and is expected to reach US$ 690.9 Billion by 2033, expanding at a CAGR of 7.8% between 2022 and 2033. In recent years, a significant focus is on how to employ advanced analytics, customized drugs, patient data, and other tools to better …

Demand for Monoclonal Antibodies and RNA Vaccines to Drive Cholesterol API Market Across Europe | Germany to Register 4.9% CAGR States FMI

The global Cholesterol Active Pharmaceutical Ingredient (API) Market is projected to be valued at US$ 269.0 Million by the end of 2022, and to grow at a CAGR of 4.7% between 2022 and 2032. By 2032, the global market for cholesterol API is expected to be worth US$ 426.9 Million. Germany is predicted to remain …